Profound Medical Corp.

NASDAQ (USD): Profound Medical Corp. (PROF)

Last Price

6.22

Today's Change

-0.11 (1.73%)

Day's Change

6.20 - 6.34

Trading Volume

41,855

Overview

Market Cap

186 Million

Shares Outstanding

30 Million

Avg Volume

79,993

Avg Price (50 Days)

7.41

Avg Price (200 Days)

8.15

PE Ratio

-4.64

EPS

-1.34

Earnings Announcement

05-Mar-2025

Previous Close

6.33

Open

6.31

Day's Range

6.2 - 6.3397

Year Range

6.19 - 11.42

Trading Volume

41,855

Price Change Highlight

1 Day Change

-1.74%

5 Day Change

-3.42%

1 Month Change

-20.15%

3 Month Change

-21.37%

6 Month Change

-34.53%

Ytd Change

-21.27%

1 Year Change

-27.08%

3 Year Change

-34.32%

5 Year Change

-65.17%

10 Year Change

-35.94%

Max Change

-35.94%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment